XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.3

License Agreements (Details) $ in Millions		3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 22, 2022 USD ($) payment	Dec. 31, 2023 USD ($)	Sep. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)
Lonza milestone payment
License Agreements
Amount of license costs payable			$ 0.0
Lonza milestone payment | Research and development
License Agreements
License fee		$ 0.4	0.4
Wuxi Biologics License
License Agreements
Amount of license costs payable			$ 0.0
Agreement with Pfizer
License Agreements
Number of development and regulatory milestone payments | payment	11
Maximum amount of development and regulatory milestone payments	$ 70.0
Maximum amount of sales milestone payments	$ 525.0
Maximum annual earned royalty at a marginal royalty rate	20.00%
Development Of research and development				$ 1.0

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 15
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480123/805-50-15-3

+ Details

Name:	us-gaap_AssetAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of license costs payable.

+ References

No definition available.

+ Details

Name:	zura_AccruedLicenseCosts
Namespace Prefix:	zura_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The amount of development milestone recognized as a component of research and development.

+ References

No definition available.

+ Details

Name:	zura_AmountOfDevelopmentMilestoneRecognizedAsComponentOfResearchAndDevelopment
Namespace Prefix:	zura_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Represents the maximum amount of development and regulatory milestone payments based on respective thresholds of net sales of products (developed from the licensed compound) (the "Products") in asset acquisition.

+ References

No definition available.

+ Details

Name:	zura_AssetAcquisitionConsiderationMaximumDevelopmentAndRegulatoryMilestonePaymentsBasedOnRespectiveThresholdsOfNetSalesOfProducts
Namespace Prefix:	zura_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Represents the maximum percentage of payment of annual earned royalty at a marginal royalty rate.

+ References

No definition available.

+ Details

Name:	zura_AssetAcquisitionConsiderationMaximumPercentageOfPaymentOfAnnualEarnedRoyaltyAtMarginalRoyaltyRate
Namespace Prefix:	zura_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the maximum amount of sales milestone payments based on respective thresholds of net sales of products (developed from the licensed compound) (the "Products") in asset acquisition.

+ References

No definition available.

+ Details

Name:	zura_AssetAcquisitionConsiderationMaximumSalesMilestonePaymentsBasedOnRespectiveThresholdsOfNetSalesOfProducts
Namespace Prefix:	zura_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Represents the number of development and regulatory milestone payments in asset acquisition.

+ References

No definition available.

+ Details

Name:	zura_AssetAcquisitionConsiderationNumberOfDevelopmentAndRegulatoryMilestonePayments
Namespace Prefix:	zura_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount represents of license expense.

+ References

No definition available.

+ Details

Name:	zura_LicenseExpense
Namespace Prefix:	zura_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=zura_LonzaLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=zura_WuxiBiologicsLicenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AssetAcquisitionAxis=zura_LicenseAgreementAndSeriesA1SubscriptionAndShareholdersAgreementWithPfizerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: